Search

Search Results

• 

  Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache

  Simona Guerzoni, Flavia Lo Castro, Carlo Baraldi, Daria Brovia, Fabio Tascedda, Veronica Rivi, Luca Pani

  07-05-2024

  https://doi.org/10.4081/cc.2024.15760

  3547

  PDF: 809

• PO-86 | CGRP, VIP and PACAP plasmatic levels in migraine patients before and after anti-CGRP(R) monoclonal antibodies prophylaxis Alessia Bellotti,¹ Davide Chiasserini,² Alfredo Megaro,² Daniela Fruttini,³ Pierluigi Navarra,⁴ Giuseppe Tringali,⁴ Paolo Calabresi,⁵ Lucilla Parnetti,¹ Paola Sarchielli¹ | ¹Department of Medicine and Surgery, Section of Neurology, University of Perugia, Perugia, Italy; ²Department of Medicine and Surgery, Section of Physiology and Biochemistry, University of Perugia, Perugia, Italy; ³Department of Medicine and Surgery, Section of Internal Medicine, University of Perugia, Perugia, Italy; ⁴Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Catholic University Medical School, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy; ⁵Department of Medicine and Surgery, Section of Neurology, Catholic University Medical School, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy

  Societò Italiana per lo Studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15910

  294

• PO-43 | Eptinezumab in migraine patients unresponsive to prior subcutaneous CGRP(-R) monoclonal antibody treatment: a retrospective case series Elena Cresta, Irene Mattioli, Michele Di Pasquale, Alice Lanfranchi, Renata Rao, Alessandro Padovani | Neurology Unit and Headache Centre, Dipartimento di continuità di cura e fragilità, ASST Spedali Civili e Università degli studi di Brescia, Brescia, Italy

  Società Italiana per lo Studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15865

  266

• PO-19 | Unraveling the spectrum of migraine resistant to treatments: searching for novel biological PHEnotypes and theRApeutic approaches (SPHERA project) M. Giraudo,^1,2 R. De Icco,^1,2 G. Vaghi,^1,2 V. Grillo,^1,2 F. Bighiani,^1,2 M. Corrado,² A. Antoniazzi,^1,2 F. Cammarota,^1,2 B. Agostini,^1,2 A. Solfrizzi,^1,2 M. Allena,² E. Guaschino,² N. Ghiotto,² R. Greco,² C. Demartini,² A. Zanaboni,^1,2 M. Francavilla,^1,2 S. Facchetti,^1,2 G. Sances,² C. Tassorelli^1,2 | ¹Department of Brain and Behavioral Sciences, University of Pavia; ²Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy

  Società Italiana per lo Studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15840

  240

• OC-17 | Profiling miR-30a expression in patients with episodic and chronic migraine Elisa Rubino,^1,2 Elisa Maria Piella,¹ Giulia Cicilese,^1,3 Silvia Boschi,¹ Alberto Mario Chiarandon,¹ Elena Tamagno,^1,3 Michela Guglielmotto,^1,3 Innocenzo Rainero^1,2 | ¹Department of Neuroscience “Rita Levi Montalcini”, University of Turin, Turin, Italy; ²Headache Center, Department of Neuroscience and Mental Health, AOU Città della Salute e della Scienza di Torino; ³Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano (TO), Italy

  Società Italiana per lo Studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15814

  135
• 

  Plasma CGRP but not PACAP-38 concentrations are associated with response to anti-CGRP monoclonal antibodies in migraine

  Elisa Rubino, Andrea Marcinnò, Silvia Boschi, Elisa Maria Piella, Alberto Mario Chiarandon, Fausto Roveta, Erica Gallo, Innocenzo Rainero

  26-11-2025

  https://doi.org/10.4081/cc.2025.15790

  562

  PDF: 176